Treatment with CAN-2409, an immune-modulating anticancer therapy, showed promising trends toward improved survival in a Phase 2 clinical trial involving…
Articles by Marisa Wexler, MS
The presence of more than one high-risk genetic abnormality is associated with dramatically more aggressive multiple myeloma, a study…
Aptose Biosciences will be testing a higher dose of tuspetinib as part of a triple-combination regimen that’s being…
The U.S. Food and Drug Administration (FDA) has agreed to review an application from Regeneron Pharmaceuticals seeking the…
A triple-combination therapy using tuspetinib, Aptose Biosciences‘ experimental oral therapy, is showing potential in treating adults with newly…
A new blood test called PAC-MANN can detect the most common type of pancreatic cancer with high accuracy, according…
An experimental immune-modulating therapy called KROS 101 was able to activate immune cells to kill glioma cells in laboratory…
The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to Gradalis’ experimental…
Treatment with the cancer vaccine galinpepimut-S (GPS) is showing promise to potentially improve survival in people with acute myeloid leukemia…
Certain immunotherapies may be effective in some cases of pancreatic neuroendocrine neoplasms (Pan-NEN), a rare type of pancreatic cancer,…